{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:57:31Z","timestamp":1786604251898,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12805-3","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:07:09Z","timestamp":1734005229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patient-reported outcomes in conservatively managed cerebral cavernous malformations"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9744-8544","authenticated-orcid":false,"given":"Abel Clemens Adriaan","family":"Sandmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-4458","authenticated-orcid":false,"given":"Marinus Abraham","family":"Kempeneers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-8791","authenticated-orcid":false,"given":"Ren\u00e9","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-0265","authenticated-orcid":false,"given":"William Peter","family":"Vandertop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-5470","authenticated-orcid":false,"given":"Dagmar","family":"Verbaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-982X","authenticated-orcid":false,"given":"Jonathan M.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"12","key":"12805_CR1","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/strokeaha.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA (2008) Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 39(12):3222\u20133230. https:\/\/doi.org\/10.1161\/strokeaha.108.515544","journal-title":"Stroke"},{"issue":"11","key":"12805_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMra2305116","volume":"390","author":"ER Smith","year":"2024","unstructured":"Smith ER (2024) Cavernous malformations of the central nervous system. N Engl J Med 390(11):1022\u20131028. https:\/\/doi.org\/10.1056\/NEJMra2305116","journal-title":"N Engl J Med"},{"issue":"7","key":"12805_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","volume":"74","author":"KD Flemming","year":"2017","unstructured":"Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD Jr, Mielke MM, Roberts RO, Kremers W, Knopman DS, Petersen RC, Jack CR Jr (2017) Population-based prevalence of cerebral cavernous malformations in older adults: mayo clinic study of aging. JAMA Neurol 74(7):801\u2013805. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0439","journal-title":"JAMA Neurol"},{"issue":"5","key":"12805_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, Awad IA, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80(5):665\u2013680. https:\/\/doi.org\/10.1093\/neuros\/nyx091","journal-title":"Neurosurgery"},{"issue":"3","key":"12805_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s1474-4422(12)70004-2","volume":"11","author":"R Al-Shahi Salman","year":"2012","unstructured":"Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ, Counsell CE, Murray GD, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP (2012) Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol 11(3):217\u2013224. https:\/\/doi.org\/10.1016\/s1474-4422(12)70004-2","journal-title":"Lancet Neurol"},{"key":"12805_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241246868","author":"ACA Sandmann","year":"2024","unstructured":"Sandmann ACA, Kempeneers MA, van den Berg R, Verbaan D, Vandertop WP, Coutinho JM (2024) Clinical course of patients with conservatively managed cerebral cavernous malformations. Eur Stroke J. https:\/\/doi.org\/10.1177\/23969873241246868","journal-title":"Eur Stroke J"},{"issue":"4","key":"12805_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s1474-4422(16)00039-9","volume":"15","author":"R Al-Shahi Salman","year":"2016","unstructured":"Al-Shahi Salman R, Kitchen N, Thomson J, Ganesan V, Mallucci C, Radatz M (2016) Top ten research priorities for brain and spine cavernous malformations. Lancet Neurol 15(4):354\u2013355. https:\/\/doi.org\/10.1016\/s1474-4422(16)00039-9","journal-title":"Lancet Neurol"},{"key":"12805_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00096-6","author":"M Eriksson","year":"2024","unstructured":"Eriksson M, Hayat R, Kinsella E, Lewis K, White D, Boyd J, Bullen A, Maclean M, Stoddart A, Phair S, Evans H, Noakes J, Alexander D, Keerie C, Linsley C, Milne G, Norrie J, Farrar N, Realpe A, White P (2024) Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(24)00096-6","journal-title":"Lancet Neurol"},{"issue":"6","key":"12805_CR9","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/strokeaha.117.018912","volume":"49","author":"M Reeves","year":"2018","unstructured":"Reeves M, Lisabeth L, Williams L, Katzan I, Kapral M, Deutsch A, Prvu-Bettger J (2018) Patient-reported outcome measures (PROMs) for acute stroke: rationale, methods and future directions. Stroke 49(6):1549\u20131556. https:\/\/doi.org\/10.1161\/strokeaha.117.018912","journal-title":"Stroke"},{"key":"12805_CR10","unstructured":"https:\/\/www.metropoolregioamsterdam.nl\/over-mra\/."},{"issue":"4","key":"12805_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3174\/ajnr.A4696","volume":"37","author":"JA Hirsch","year":"2016","unstructured":"Hirsch JA, Nicola G, McGinty G, Liu RW, Barr RM, Chittle MD, Manchikanti L (2016) ICD-10: history and context. AJNR Am J Neuroradiol 37(4):596\u2013599. https:\/\/doi.org\/10.3174\/ajnr.A4696","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"12805_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"12805_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337\u2013343. https:\/\/doi.org\/10.3109\/07853890109002087","journal-title":"Ann Med"},{"issue":"7","key":"12805_CR14","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","volume":"27","author":"RD Hays","year":"2018","unstructured":"Hays RD, Spritzer KL, Schalet BD, Cella D (2018) PROMIS(\u00ae)-29 v2.0 profile physical and mental health summary scores. Qual Life Res 27(7):1885\u20131891. https:\/\/doi.org\/10.1007\/s11136-018-1842-3","journal-title":"Qual Life Res"},{"issue":"4","key":"12805_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA (2016) Dutch tariff for the five-level version of EQ-5D. Value Health 19(4):343\u2013352. https:\/\/doi.org\/10.1016\/j.jval.2016.01.003","journal-title":"Value Health"},{"issue":"5","key":"12805_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","volume":"22","author":"D Cella","year":"2019","unstructured":"Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, Yount S, Cook KF, Gershon RC, Amtmann D, DeWalt DA, Pilkonis PA, Stone AA, Weinfurt K, Reeve BB (2019) PROMIS(\u00ae) adult health profiles: efficient short-form measures of seven health domains. Value Health 22(5):537\u2013544. https:\/\/doi.org\/10.1016\/j.jval.2019.02.004","journal-title":"Value Health"},{"issue":"9","key":"12805_CR17","doi-asserted-by":"publisher","first-page":"CAT.24.0045","DOI":"10.1056\/CAT.24.0045","volume":"5","author":"CB Terwee","year":"2024","unstructured":"Terwee CB, Ahmed S, Alhasani R, Alonso J, Bartlett SJ, Chaplin JE, Cho J, Choi H, Correia H, Efficace F, Fischer F, Glinkowski W, Kang D, Mercieca-Bebber R, Mucsi I, Oishi T, Pan A-W, Roorda LD, Rose M, Schalet BD, Schmidt S, Tinsley M, Valderas JM, Vilagut G, Yuan C, Cella D (2024) Comparable real-world patient-reported outcomes data across health conditions, settings, and countries: the PROMIS International Collaboration. NEJM Catal 5(9):CAT.24.0045. https:\/\/doi.org\/10.1056\/CAT.24.0045","journal-title":"NEJM Catal"},{"issue":"1","key":"12805_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07853890.2022.2149849","volume":"55","author":"CB Terwee","year":"2023","unstructured":"Terwee CB, Roorda LD (2023) Country-specific reference values for PROMIS(\u00ae) pain, physical function and participation measures compared to US reference values. Ann Med 55(1):1\u201311. https:\/\/doi.org\/10.1080\/07853890.2022.2149849","journal-title":"Ann Med"},{"issue":"8","key":"12805_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273287","volume":"17","author":"EBM Elsman","year":"2022","unstructured":"Elsman EBM, Flens G, de Beurs E, Roorda LD, Terwee CB (2022) Towards standardization of measuring anxiety and depression: differential item functioning for language and Dutch reference values of PROMIS item banks. PLoS ONE 17(8):e0273287. https:\/\/doi.org\/10.1371\/journal.pone.0273287","journal-title":"PLoS ONE"},{"issue":"3","key":"12805_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/26320843221089628","volume":"3","author":"CB Terwee","year":"2022","unstructured":"Terwee CB, Elsman EB, Roorda LD (2022) Towards standardization of fatigue measurement: psychometric properties and reference values of the PROMIS Fatigue item bank in the Dutch general population. Res Methods Med Health Sci 3(3):86\u201398. https:\/\/doi.org\/10.1177\/26320843221089628","journal-title":"Res Methods Med Health Sci"},{"issue":"2","key":"12805_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13753","volume":"32","author":"CB Terwee","year":"2023","unstructured":"Terwee CB, van Litsenburg RRL, Elsman EBM, Roorda LD (2023) Psychometric properties and reference values of the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep item banks in the Dutch general population. J Sleep Res 32(2):e13753. https:\/\/doi.org\/10.1111\/jsr.13753","journal-title":"J Sleep Res"},{"key":"12805_CR22","unstructured":"IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp"},{"key":"12805_CR23","unstructured":"MedCalc\u00ae Statistical Software version 22.016 (MedCalc Software Ltd, Ostend, Belgium; 2023)"},{"key":"12805_CR24","doi-asserted-by":"publisher","first-page":"1338941","DOI":"10.3389\/fneur.2024.1338941","volume":"15","author":"J Meessen","year":"2024","unstructured":"Meessen J, Abete-Fornara G, Zarino B, Castori M, Tassi L, Carriero MR, D\u2019Alessandris QG, Al-Shahi Salman R, Blanda A, Nicolis EB, Novelli D, Caruana M, Vasam\u00ec A, Lanfranconi S, Latini R (2024) Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial. Front Neurol 15:1338941. https:\/\/doi.org\/10.3389\/fneur.2024.1338941","journal-title":"Front Neurol"},{"issue":"6","key":"12805_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2595","volume":"12","author":"L Rauschenbach","year":"2022","unstructured":"Rauschenbach L, Bartsch P, Santos AN, Lenkeit A, Darkwah Oppong M, Wrede KH, Jabbarli R, Chmielewski WX, Schmidt B, Quesada CM, Forsting M, Sure U, Dammann P (2022) Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy. Brain Behav 12(6):e2595. https:\/\/doi.org\/10.1002\/brb3.2595","journal-title":"Brain Behav"},{"issue":"2","key":"12805_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/ene.14546","volume":"28","author":"A Herten","year":"2021","unstructured":"Herten A, Chen B, Saban D, Santos A, Wrede K, Jabbarli R, Zhu Y, Schmidt B, Kleinschnitz C, Forsting M, Sure U, Dammann P (2021) Health-related quality of life in patients with untreated cavernous malformations of the central nervous system. Eur J Neurol 28(2):491\u2013499. https:\/\/doi.org\/10.1111\/ene.14546","journal-title":"Eur J Neurol"},{"issue":"12","key":"12805_CR27","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1161\/strokeaha.120.033487","volume":"52","author":"H Kim","year":"2021","unstructured":"Kim H, Flemming KD, Nelson JA, Lui A, Majersik JJ, Cruz MD, Zabramski J, Trevizo O, Lanzino G, Zafar A, Torbey M, Mabray MC, Robinson M, Narvid J, Lupo J, Thompson RE, Hanley DF Jr, McBee N, Treine K, Ostapkovich N, Stadnik A, Piedad K, Hobson N, Carroll T, Shkoukani A, Carri\u00f3n-Penagos J, Mendoza-Puccini C, Koenig JI, Awad I (2021) Baseline characteristics of patients with cavernous angiomas with symptomatic hemorrhage in Multisite Trial Readiness Project. Stroke 52(12):3829\u20133838. https:\/\/doi.org\/10.1161\/strokeaha.120.033487","journal-title":"Stroke"},{"issue":"12","key":"12805_CR28","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00701-019-04075-0","volume":"161","author":"S Kumar","year":"2019","unstructured":"Kumar S, Lanzino G, Flemming KD (2019) Affected health domains in patients with brainstem cavernous malformations. Acta Neurochir (Wien) 161(12):2521\u20132526. https:\/\/doi.org\/10.1007\/s00701-019-04075-0","journal-title":"Acta Neurochir (Wien)"},{"key":"12805_CR29","doi-asserted-by":"publisher","DOI":"10.1055\/a-1994-9435","author":"AA Gajjar","year":"2023","unstructured":"Gajjar AA, Jain A, Le AH, Salem MM, Jankowitz BT, Burkhardt JK (2023) Cerebral cavernous malformations patient perception analysis via social media. J Neurol Surg A Cent Eur Neurosurg. https:\/\/doi.org\/10.1055\/a-1994-9435","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"12805_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.wneu.2016.08.014","volume":"95","author":"JF Cornelius","year":"2016","unstructured":"Cornelius JF, K\u00fcrten K, Fischer I, H\u00e4nggi D, Steiger HJ (2016) Quality of life after surgery for cerebral cavernoma: brainstem versus nonbrainstem location. World Neurosurg 95:315\u2013321. https:\/\/doi.org\/10.1016\/j.wneu.2016.08.014","journal-title":"World Neurosurg"},{"issue":"5\u20136","key":"12805_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000480125","volume":"44","author":"VC Bicalho","year":"2017","unstructured":"Bicalho VC, Bergmann A, Domingues F, Frossard JT, de Souza J (2017) Cerebral cavernous malformations: patient-reported outcome validates conservative management. Cerebrovasc Dis 44(5\u20136):313\u2013319. https:\/\/doi.org\/10.1159\/000480125","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12805-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:57:21Z","timestamp":1738173441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12805"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12805-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JMC received financial support from the Dutch Heart Foundation, Medtronic, Bayer and Boehringer (all fees were paid to his employer), and is co-founder and shareholder of TrianecT. RvdB has a non-personal hospital consultancy at Johnson & Johnson (CERENOVUS). All other authors declare that there are no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments. This study was waived for ethical approval by the Institutional Review Board of the Amsterdam UMC because it did not fall under the scope of the Medical Research Involving Human Subjects Act (WMO).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent for the use of clinical data and data derived from the questionnaire.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"12"}}